Does Warfarin or Rivaroxaban at Low Anticoagulation Intensity Provide a Survival Benefit to Asian Patients With Atrial Fibrillation?
Background: Low-dose rivaroxaban and low-intensity warfarin are widely used in Asia for patients with atrial fibrillation (AF). However, in Asians, it is unclear whether low-dose rivaroxaban and low-intensity warfarin can improve the prognosis of AF. In this study, we investigate the survival benefi...
Guardado en:
Autores principales: | Dong Lin, Yequn Chen, Jian Yong, Shiwan Wu, Yan Zhou, Weiping Li, Xuerui Tan, Ruisheng Liu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ba3e96bbe20c43cf981c519eddc6192a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
ANTICOAGULATION CONTROL AMONG PATIENTS WITH ATRIAL FIBRILLATION
por: Amer Rauf, et al.
Publicado: (2020) -
Characteristics of warfarin under-prescription in older adults with atrial fibrillation
por: Sana Rashid, et al.
Publicado: (2021) -
Association of anticoagulant-related bleeding events with cancer detection in atrial fibrillation: A systematic review and meta-analysis
por: Anastasios Papanastasiou, et al.
Publicado: (2021) -
Antithrombotic Therapy in Elderly Patients with Atrial Fibrillation: The State of the Problem in the Real Clinical Practice of a Family Medicine Doctor
por: Bazira Kanat кyzy, et al.
Publicado: (2021) -
Stroke prevention in the elderly atrial fibrillation patient with comorbid conditions: focus on non-vitamin K antagonist oral anticoagulants
por: Turagam MK, et al.
Publicado: (2015)